COMBINATION OF XENON AND AN ANTIOXIDANT TO CONTROL A PARKINSON'S DISEASE-TYPE NEURODEGENERATIVE DISEASE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15312198

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a drug combination including xenon gas and at least one antioxidant, in liquid or solid form, for use in treating, slowing, or preventing neurological damage following a neurodegenerative disease in a human being. Preferably, the xenon content is 10% to 80% by volume. Also, the antioxidant is preferably vitamin E, a vitamin E analog, or a vitamin E derivative. The neurodegenerative disease is Parkinson's disease or a disease related to Parkinson's disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
L'INSTITUT DE CERVEAU ET DE LA MOELLE EPINIEREFACULTE DE MEDICINE PITIÉ-SALPÊTRIÈRE 47-83 BOULEVARD DE L'HÔPITAL PARIS 75013

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
HIRSCH, Etienne Versailles, FR 4 1
LAVAUR, Jérémie Paris, FR 4 1
LEMAIRE, Marc Paris, FR 71 421
MICHEL, Patrick Paris, FR 87 1364

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation